A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trials

BACKGROUND: Constipation is a common side effect of antimuscarinic treatment for overactive bladder (OAB). This review evaluates the incidence and impact of constipation on the lives of patients with OAB being treated with darifenacin. METHODS: Constipation data from published Phase III and Phase II...

Descripción completa

Detalles Bibliográficos
Autores principales: Tack, Jan, Wyndaele, Jean-Jacques, Ligozio, Greg, Egermark, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468023/
https://www.ncbi.nlm.nih.gov/pubmed/23055780
http://dx.doi.org/10.2147/DHPS.S26580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468023/
https://www.ncbi.nlm.nih.gov/pubmed/23055780
http://dx.doi.org/10.2147/DHPS.S26580

Ejemplares similares